Week 7: Hereditary hematologic malignancies Flashcards

1
Q

What are some factors that can complicate family history assessment for cancer?

A

-Incomplete penetrance
-Mild phenotypes
-Variable expressivity
-De novo cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List some family history red flags for hereditary heme maligancy?

A

-AML or MDS before 50yr
-Solid tumors before 50yr
-Childhood cancers
-Low platelet/platelet defects/bleeding concerns
-Bone marrow failure/aplastic anemia
-Hx of BMT
-Premature greying or hair loss
-Easy bruising
-Immunodeficiency
-Hearing loss
-Skeletal anomalies
-Cafe au lait spots
-Heart defects
-Eczema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The more homogenous the diagnoses in a family, the ____ yield of genetic testing? (heme lecture)

A

Higher!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The more heterogenous the diagnoses in the family, the ___ the yield of genetic testing? (heme lecture)

A

Lower!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some clues in family hx that would indicate a relative had an acute blood cancer?

A

-Passed away within 5yrs diagnosis
-If they had a BMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a clue that would indicate a relative had a chronic blood cancer?

A

If they had active surveillance without treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the standard of care for diagnosing myeloid malignancies?

A

Molecular/somatic testing

Includes several genes with germline implications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a consideration/risk associated with molecular/somatic testing for hematologic malignancies?

A

Testing can identify germline variants incidentally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F Molecular/somatic testing for heme malignancies is insufficient for evaluation of germline variants

A

True! It is not comprehensive and may not evaluate mutations in all regions, needs further evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most commonly mutated gene in HHM?

A

DDX41

-Lifetime risk 20-30%
-Moderate penetrance
-Male predominance
-Median age at dx 69yr (difficult to differentiate from sporadic cases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F peripheral blood is not an appropriate sample for analyzing variants for patients with leukemia, MDS, some lymphomas

A

True!

peripheral blood in these = tumor tissue

This tumor tissue not always useful as it may contain only somatic mutations associated with the cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What layer of blood is used for molecular analysis? What types of cells does this layer contain?

A

Buffy coat!

Contains leukocytes and platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F Blood/saliva/buccal sample is not an appropriate for presymptomatic relatives of someone with heme malignancy?

A

False!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the gold standard specimens in HHMs?

A

Skin punch biopsy

Saliva not appropriate because it still collects DNA from same WBC components as blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some scenarios in which blood is not ideal for germline testing?

A

-Recent transfusion (<4wks)
-Received recent packed cell/platelet transfusion (<2wks)
-Evidence of active hematologic dysplasia (MDS or malignancy)
-Hx of allogenic HSCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a consideration/risk pertaining to MRD-SCT for DDX41 variants?

A

Patient receiving transplant gets donor derived leukemia–recurrence of leukemia from donor’s variant